Immediate Impact
53 standout
Citing Papers
The neuropathobiology of multiple sclerosis
2024 Standout
Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems
2023 Standout
Works of David Li being referenced
Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis
2011
Benefits of high-dose, high-frequency interferon beta-1a in relapsing–remitting multiple sclerosis are sustained to 16 months: Final comparative results of the EVIDENCE trial
2005
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| David Li | 60 | 238 | 36 | 142 | 105 | 26 | 469 | |
| Mohammed Aljumah | 33 | 196 | 76 | 96 | 47 | 41 | 523 | |
| Caroline Protin | 14 | 144 | 29 | 93 | 86 | 19 | 553 | |
| Veikko Kähärä | 44 | 52 | 10 | 314 | 75 | 24 | 551 | |
| Maxwell Laurans | 25 | 97 | 26 | 171 | 18 | 39 | 505 | |
| Alfredo Madrid-García | 92 | 151 | 8 | 69 | 61 | 32 | 456 | |
| Sheng-Ping ChangLai | 14 | 57 | 8 | 79 | 124 | 19 | 532 | |
| Warren L. Felton | 23 | 86 | 16 | 161 | 26 | 16 | 415 | |
| A. B. Ayers | 41 | 70 | 25 | 48 | 35 | 34 | 545 | |
| P S Klimiuk | 24 | 234 | 21 | 16 | 52 | 25 | 513 | |
| Mark N. Pernik | 61 | 57 | 29 | 70 | 20 | 34 | 420 |
All Works
Loading papers...